Concepedia
Statistics
Publications
8
Citations
472
H-Index
Active since
2012
Affiliations
University of Zurich(Current)
Osnabrück University
Roche Pharma AG (Germany)
Martin Schwill is an author at University of Zurich specializing in oncology, life sciences, and molecular oncology.
Publications per year
2012–2025
Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding to the Extracellular Domain of HER2
Christian Jöst, Johannes Schilling, Rastislav Tamaskovic et al. · Structure · 2013 · 138 citations · Full text
Medicine, Molecular Biology, Oncology +15
Designed Ankyrin Repeat Proteins (DARPins)
Rastislav Tamaskovic, Manuel Simon, Nikolas Stefan et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 2012 · 119 citations
Life Sciences, Biochemistry, Molecular Biology +11
Engineering an anti-HER2 biparatopic antibody with a multimodal mechanism of action
Florian Kast, Martin Schwill, Jakob C. Stüber et al. · Nature Communications · 2021 · 62 citations · Full text
Pharmacy, Medicinal Chemistry, Oncology +17
Intermolecular biparatopic trapping of ErbB2 prevents compensatory activation of PI3K/AKT via RAS–p110 crosstalk
Rastislav Tamaskovic, Martin Schwill, Gabriela Nagy‐Davidescu et al. · Nature Communications · 2016 · 59 citations · Full text
Life Sciences, Biochemistry, Oncology +17
Systemic analysis of tyrosine kinase signaling reveals a common adaptive response program in a HER2-positive breast cancer
Martin Schwill, Rastislav Tamaskovic, Aaron S. Gajadhar et al. · Science Signaling · 2019 · 48 citations
Life Sciences, Cancer Biology, Oncology +15
1–5 of 8